Abolon has been the exclusive adviser to Medipart AG, Switzerland, (“Medipart”) which has signed a share purchase agreement on 30th August 2019 to sell its stake of 73.4% in the share capital of HumanOptics AG (“HumanOptics” or the “Company”) to a Chinese investor. The closing of the sale is subject to customary closing conditions, including approval by the Chinese public authorities.
HumanOptics is a listed stock corporation with registered office in Erlangen, Germany. The Company is active in the development, manufacturing and distribution of implantable premium intraocular solutions. The Company’s shares are listed in the open market of the Frankfurt Stock Exchange. Its market capitalisation was € 56.5 million as of 29 August 2019, pre announcement of the transaction.
Abolon AG is a healthcare-focused advisory firm with a long track-record in medical devices transactions. This transaction follows a series of transactions involving publicly listed entities including Sigvaris’ acquisition of compression stockings business Pani Teresa Medical (Warsaw stock exchange) and WaveLight’s (German stock exchange) sale of its urology laser unit.
English 
Deutsch